Refreshed just now
S. 5797 was introduced in the Senate and referred to the Finance Committee, directing HHS to create a Medicare demonstration project to expand access to biosimilar biologics.
Why it’s here: A federal bill creating a Medicare demonstration project for biosimilar access falls under biotechnology federal policy (drug pricing and access affecting biotech innovation), though it is a routine referral action with thin substance.
Trace across the boardItem
3d agoCongressSenate Committee on FinanceS. 5797 was introduced in the Senate and referred to the Finance Committee, directing HHS to create a Medicare demonstration project to expand access to biosimilar biologics.S. 5797BiotechDetails3 linked
Connected
3 links- NewsSTAT+: Medicare pilot will test ‘food is medicine’ and other lifestyle programs to counter chronic diseasesBoth involve Medicare, Department of Health and Human Services
- NewsSTAT+: New documents raise more questions about Medicare’s AI prior-authorization experimentBoth involve Medicare
- NewsMedicare’s AI-assisted coverage review pilot hit early snags, documents showBoth involve Medicare
About
- Medicare
- Senate Finance Committee Democrats
- Department of Health and Human Services